Hainan Province issued "Several Policy Measures on Further Supporting the High-quality Development of Biomedical Industry in Hainan Province"

The General Office of the People's Government of Hainan Province has issued the "Several Policy Measures of Hainan Province on Further Supporting the High-Quality Development of the Biomedical Industry". Among them, it proposes to continue to increase support for the research and development of innovative drugs and medical devices. The provincial biomedical industry research and development voucher policy will continue to be implemented, providing a funding reward of 400,000 to 10 million yuan for the entire process of preclinical research, clinical trials, industrialization of new achievements, etc., based on phased achievements. Continued support for the growth and strength of the modern biomedical industry. Encouraging companies to participate in national centralized drug procurement, providing up to 3% of the actual sales amount based on the winning bid unit price for winning varieties in the national drug centralized procurement, with a maximum reward of 3 million yuan. Encouraging companies inside and outside the province to merge and reorganize local pharmaceutical companies in accordance with the law, revitalizing assets and developing and growing, providing a 50% interest subsidy for bank loans obtained through merger and reorganization, continuous subsidy for 2 years, with a maximum subsidy of 5 million yuan. Encouraging companies to obtain international certification, providing a one-time reward of 2 million yuan for pharmaceutical and medical device companies that obtain international authoritative certification according to regulations.